Zobrazeno 1 - 10
of 40
pro vyhledávání: '"G M, Proshkina"'
Autor:
G. M. Proshkina, S. M. Deev, P V Shegai, Konstantin Kokov, A D Kaprin, B V Egorova, Anna D. Plyutinskaya, A. A. Pankratov, V. A. Golovachenko, M S Vorontsova, E N Lebedenko, E. R. Nemtsova, D. Yu. Chuvilin, A. A. Shulga
Publikováno v:
Bulletin of Experimental Biology and Medicine. 171:627-632
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides 177Lu (ZHER2-HSA-chelator-177Lu) or 212Pb (ZHER2-HSA-chelator-212Pb). The objective was to e
Autor:
Sergey M. Deyev, Victoria O. Shipunova, Anton A. Popov, Vladislav D Soloviev, G. M. Proshkina, Polina A. Kotelnikova, Olga A Kolesnikova, Maxim P. Nikitin
Publikováno v:
ACS Omega
ACS Omega, Vol 6, Iss 24, Pp 16000-16008 (2021)
ACS Omega, Vol 6, Iss 24, Pp 16000-16008 (2021)
Targeted drug delivery is one of the most intriguing and challenging issues in modern biomedicine. For active targeting, full-size IgG molecules (150 kDa) are usually used. Recent studies have revealed that small artificial polypeptide scaffolds such
Autor:
E. I. Shramova, M. V. Shilova, G. M. Proshkina, Victoria O. Shipunova, Alexey A. Schulga, S. M. Deyev
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:1156-1161
In this work for the first time we demonstrate the possibility of ribonuclease barnase delivery to HER2-positive human cancer cells in a liposomal form. The principle of loading liposomes with ribonuclease is based on the electrostatic interaction of
Publikováno v:
Acta Naturae
Today, it has become apparent that innovative treatment methods, including those involving simultaneous diagnosis and therapy, are particularly in demand in modern cancer medicine. The development of nanomedicine offers new ways of increasing the the
Autor:
Anzhelika Vorobyeva, A. Medvedeva, A. Shulga, V. Chernov, G. M. Proshkina, M. S. Lar’kina, R. Zel'chan, Vladimir M. Tolmachev, O. Bragina, Anna Orlova, Sergey M. Deyev
Publikováno v:
Medical Radiology and radiation safety. 65:37-41
Purpose: Evaluation of a radiopharmaceutical based on 99mTc-labeled targeted molecules DARPin9_29 for radionuclide diagnostics of malignancies with Her2/neu overexpression. Material and methods: The DARPin9_29 sequence was amplified from the plasmid
Autor:
M V, Novoselova, E I, Shramova, O V, Sergeeva, E Y, Shcherbinina, S V, Perevoschikov, P, Melnikov, O Yu, Griaznova, I S, Sergeev, E V, Konovalova, A A, Schulga, G M, Proshkina, T S, Zatsepin, S M, Deyev, D A, Gorin
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 47:102612
Nanomedicine has revolutionized the available treatment options during the last decade, but poor selectivity of targeted drug delivery and release is still poses a challenge. In this study, doxorubicin (DOX) and magnetite nanoparticles were encapsula
Autor:
Georgij B Telegin, E. I. Shramova, N.A. Zolotova, G. M. Proshkina, D.S. Dzhalilova, M. V. Shilova, Sergey M. Deyev, Anastasiya V. Ryabova
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 340
For precise ligation of a targeting and cytotoxic moiety, the use of Barnase-Barstar pair as a molecular glue is proposed for the first time. Targeting was mediated through the use of a scaffold protein DARPin_9–29 specific for the human epidermal
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 4975, p 4975 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 4975, p 4975 (2021)
Cancer cells frequently overexpress specific surface receptors providing tumor growth and survival which can be used for precise therapy. Targeting cancer cell receptors with protein toxins is an attractive approach widely used in contemporary experi
Autor:
A A, Pankratov, E R, Nemtsova, A D, Plyutinskaya, M S, Vorontsova, D Yu, Chuvilin, B V, Egorova, K V, Kokov, S M, Deev, E N, Lebedenko, G M, Proshkina, A A, Shul'ga, V A, Golovachenko, P V, Shegai, A D, Kaprin
Publikováno v:
Bulletin of experimental biology and medicine. 171(5)
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
Autor:
Andrei V. Kabashin, G. M. Proshkina, Sergey M. Deyev, Victoria O. Shipunova, Alexey A. Schulga, E. I. Shramova, Ivan V. Zelepukin, Paras N. Prasad, Elena N. Komedchikova, Georgij B Telegin, Polina A. Kotelnikova, Hilliard L. Kutscher
Publikováno v:
ACS Nano
ACS Nano, American Chemical Society, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, American Chemical Society, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
ACS Nano, 2020, 14 (10), pp.12781-12795. ⟨10.1021/acsnano.0c03421⟩
When combined with immunotherapy, image-guided targeted delivery of chemotherapeutic agents is a promising direction for combination cancer theranostics, but this approach has so far produced only limited success due to a lack of molecular targets on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddce00ba8f18cf0d1a91f40794342a49
https://hal.archives-ouvertes.fr/hal-03097623
https://hal.archives-ouvertes.fr/hal-03097623